BMS to File for Apixaban for Stroke Prevention in Japan, US, and Europe Before Year-end

Lamberto Andreotti、CEO of Bristol-Myers Squibb Lamberto Andreotti, CEO of Bristol-Myers Squibb (BMS) of the US, announced in Tokyo on September 26 that the company plans to submit the novel anticoagulant apixaban (brand name in Europe: Eliquis) for approval in Japan,...read more